N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.30p
   
  • Change Today:
      0.30p
  • 52 Week High: 3.50p
  • 52 Week Low: 0.43p
  • Currency: UK Pounds
  • Shares Issued: 101.46m
  • Volume: 594,266
  • Market Cap: £3.35m

Latest Deals

Traded Action Notifier PriceAmountValue
10-Apr-19 Buy Nigel Theobald 44.40p 67,343 £29,900.29
10-Apr-19 Buy Nigel Theobald 4.44p 67,343 £2,990.03

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
10-Apr-19 Buy Nigel Theobald 44.40p 67,343 £29,900.29
10-Apr-19 Buy Nigel Theobald 4.44p 67,343 £2,990.03

Director Shareholdings

Notifier Holding Value*
Nigel Theobald 12,389,919 £408,867
Luke Cairns 142,660 £4,708

Major Shareholders

Notifier** Holding Value*
NIGEL JAMES THEOBALD 16,846,633 £555,939
David Farrier 12,175,510 £401,792
Peel Hunt LLP 7,436,152 £245,393
MYLES MCNULTY 4,000,000 £132,000
First Equity Limited 3,500,000 £115,500
Lynchwood Nominees Limited 690,800 £22,796
Barclays Stockbrokers Limited 447,800 £14,777
LR Nominees Limited 311,600 £10,283

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

N4 Pharma Market Data

Currency UK Pounds
Share Price 3.30p
Change Today 0.30p
% Change 10.00 %
52 Week High 3.50p
52 Week Low 0.43p
Volume 594,266
Shares Issued 101.46m
Market Cap £3.35m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.2% below the market average38.2% below the market average38.2% below the market average38.2% below the market average38.2% below the market average
68.42% below the sector average68.42% below the sector average68.42% below the sector average68.42% below the sector average68.42% below the sector average
Value
38.2% below the market average38.2% below the market average38.2% below the market average38.2% below the market average38.2% below the market average
68.42% below the sector average68.42% below the sector average68.42% below the sector average68.42% below the sector average68.42% below the sector average
Income Not Available
Growth
24.75% below the market average24.75% below the market average24.75% below the market average24.75% below the market average24.75% below the market average
35.14% below the sector average35.14% below the sector average35.14% below the sector average35.14% below the sector average35.14% below the sector average

N4 Pharma Dividends

No dividends found

Trades for 20-Jan-2020

Time Volume / Share Price
14:46 14,130 @ 3.45p
14:41 50,000 @ 3.31p
14:36 50,000 @ 3.41p
14:15 30,000 @ 3.40p
14:11 27,714 @ 3.50p

N4 Pharma Key Personnel

CEO Nigel Theobald

Top of Page